Evidence mapPaperPMID 39063944Full record

ReviewJournal of personalized medicine2024

Novel Approaches for Early Detection of Retinal Diseases Using Artificial Intelligence.

Francesco Saverio Sorrentino, Lorenzo Gardini, Luigi Fontana, Mutali Musa, Andrea Gabai, Antonino Maniaci, Salvatore Lavalle, Fabiana D'Esposito, Andrea Russo, Antonio Longo and 3 more

Abstract readReview
In one paragraph

Review in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesco Saverio SorrentinoUnit of Ophthalmology, Department of Surgical Sciences, Ospedale Maggiore, 40100 Bologna, Italy.ORCID 0000-0002-7691-8980
Lorenzo GardiniUnit of Ophthalmology, Department of Surgical Sciences, Ospedale Maggiore, 40100 Bologna, Italy.
Luigi FontanaOphthalmology Unit, Department of Surgical Sciences, Alma Mater Studiorum University of Bologna, IRCCS Azienda Ospedaliero-Universitaria Bologna, 40100 Bologna, Italy.
Mutali MusaDepartment of Optometry, University of Benin, Benin City 300238, Edo State, Nigeria.ORCID 0000-0001-7486-8361
Andrea GabaiDepartment of Ophthalmology, Humanitas-San Pio X, 20159 Milan, Italy.ORCID 0000-0002-3865-3336
Antonino ManiaciDepartment of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.ORCID 0000-0002-1251-0185
Salvatore LavalleDepartment of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.ORCID 0009-0009-5556-6259
Fabiana D'EspositoImperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, 153-173 Marylebone Rd, London NW15QH, UK.ORCID 0000-0002-7938-876X
Andrea RussoDepartment of Ophthalmology, University of Catania, 95123 Catania, Italy.
Antonio LongoDepartment of Ophthalmology, University of Catania, 95123 Catania, Italy.
Pier Luigi SuricoSchepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-7721-4694
Caterina GaglianoDepartment of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.ORCID 0000-0001-8424-0068
Marco ZeppieriDepartment of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.ORCID 0000-0003-0999-5545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn increasing amount of people are globally affected by retinal diseases, such as diabetes, vascular occlusions, maculopathy, alterations of systemic circulation, and metabolic syndrome.

aimThis review will discuss novel technologies in and potential approaches to the detection and diagnosis of retinal diseases with the support of cutting-edge machines and artificial intelligence (AI).

methodsThe demand for retinal diagnostic imaging exams has increased, but the number of eye physicians or technicians is too little to meet the request. Thus, algorithms based on AI have been used, representing valid support for early detection and helping doctors to give diagnoses and make differential diagnosis. AI helps patients living far from hub centers to have tests and quick initial diagnosis, allowing them not to waste time in movements and waiting time for medical reply.

resultsHighly automated systems for screening, early diagnosis, grading and tailored therapy will facilitate the care of people, even in remote lands or countries.

conclusionA potential massive and extensive use of AI might optimize the automated detection of tiny retinal alterations, allowing eye doctors to perform their best clinical assistance and to set the best options for the treatment of retinal diseases.

Indexed as

artificial intelligencedeep learningmachine learningmacular edemamaculopathyretinal imagingretinopathy

Identifiers

PMID39063944
PMCPMC11278069

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.